Proportionally more patients in the screening cohort received locoregional treatments (resection, transarterial chemoembolization, or transarterial radioembolization) and more patients in the non-screened cohort received either no treatment or systemic therapy as the initial treatment, although these differences did not reach statistical significance.
← all excerpts
Impact of Screening on Mortality for Patients Diagnosed with Hepatocellular Carcinoma in a Safety-Net Healthcare System: An Opportunity for Addressing Disparities.
1
—
—